152 related articles for article (PubMed ID: 18673136)
1. Nociceptin/orphanin FQ peptide receptor as a therapeutic target for obesity.
Przydzial MJ; Heisler LK
Mini Rev Med Chem; 2008 Jul; 8(8):796-811. PubMed ID: 18673136
[TBL] [Abstract][Full Text] [Related]
2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
3. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
Wtorek K; Janecka A
Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
5. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.
El Daibani A; Che T
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163856
[TBL] [Abstract][Full Text] [Related]
8. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
[TBL] [Abstract][Full Text] [Related]
9. N/OFQ-NOP System in Food Intake.
Micioni Di Bonaventura MV; Micioni Di Bonaventura E; Cifani C; Polidori C
Handb Exp Pharmacol; 2019; 254():279-295. PubMed ID: 31073870
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments.
Naydenova E; Todorov P; Zamfirova R
Vitam Horm; 2015; 97():123-46. PubMed ID: 25677770
[TBL] [Abstract][Full Text] [Related]
12. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?
Zeilhofer HU; Calò G
J Pharmacol Exp Ther; 2003 Aug; 306(2):423-9. PubMed ID: 12721334
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.
Malfacini D; Ambrosio C; Gro' MC; Sbraccia M; Trapella C; Guerrini R; Bonora M; Pinton P; Costa T; Calo' G
PLoS One; 2015; 10(8):e0132865. PubMed ID: 26248189
[TBL] [Abstract][Full Text] [Related]
16. Recently patented and promising ORL-1 ligands: where have we been and where are we going?
Largent-Milnes TM; Vanderah TW
Expert Opin Ther Pat; 2010 Mar; 20(3):291-305. PubMed ID: 20180617
[TBL] [Abstract][Full Text] [Related]
17. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
18. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
[TBL] [Abstract][Full Text] [Related]
19. NOP-Targeted Nonpeptide Ligands.
Zaveri NT; Meyer ME
Handb Exp Pharmacol; 2019; 254():37-67. PubMed ID: 31119463
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
